CardiologyOnline.net

Cardiology Xagena

Randomized controlled trials ( RCTs ) regarding use of Ranolazine for the prevention and cardioversion of atrial fibrillation have yielded conflicting results. Researchers have conducted a meta-ana ...


Available pharmacological options for rhythm control strategy in atrial fibrillation are limited by sub-optimal efficacy and potentially serious adverse events. The aim of meta-analysis was to det ...


The optimal rhythm management strategy for people with non-paroxysmal ( persistent or long-standing persistent ) atrial fibrilation is currently not well defined. Antiarrhythmic drugs have been the ...


Ondansetron ( Zofran ) is commonly used to treat vomiting in gastroenteritis, but has a United States FDA ( Food and Drug Administration ) black box warning for risk of Q wave to T wave time interval ...


A study has examined patients with chronic kidney disease ( CKD ) in stages 1, 2, 3 and 4, left ventricular dysfunction and automatic implantable cardioverter-defibrillator ( ICD ). The goal was to ...


Sarcoidosis is an important diagnostic consideration in patients with ventricular tachycardia of unknown origin. The clinical course of ventricular tachycardia as the primary presentation in patients ...


In addition to Warfarin ( Coumadin ), there are four non-vitamin K antagonist oral anticoagulants ( NOACs ) available for stroke prevention in non-valvular atrial fibrillation ( NVAF ). There are li ...


Stroke is a rare but serious complication of acute coronary syndrome. At present, no specific score exists to identify patients at higher risk. The aim of a study was to test whether each clinical v ...


After analyzing 10 years of medical tests on more than 2,700 people in a federally funded heart disease study, researchers at Johns Hopkins Medicine and elsewhere conclude that taking Calcium in the f ...


Results from the global phase 3b ENSURE-AF ( EdoxabaN vs warfarin in subjectS UndeRgoing cardiovErsion of AtrialFibrillation ) study of 2,199 patients with non-valvular atrial fibrillation ( NVAF ) un ...


Heart failure is a major health problem worldwide with no proven therapy. Low-dose Dopamine ( LDD ) has been applied to patients with heart failure to enhance diuresis and preserve renal function sinc ...


Ventricular remodeling following myocardial infarction ( MI ) is closely associated with cyclooxygenase-2 ( COX-2 ) expression. 5-methoxytryptophan ( 5-MTP ) was reported to control COX-2 expression. ...


The 2015 Guidelines for Resuscitation recommend Amiodarone ( Cordarone ) as the antiarrhythmic drug of choice in the treatment of resistant ventricular fibrillation or pulseless ventricular tachycardi ...


Heart failure with recovered or improved ejection fraction ( HFiEF ) has been proposed as a new category of heart failure. Whether HFiEF is clinically distinct from heart failure with persistently r ...


A study assessed whether the benefit of Sacubitril / Valsartan ( Entresto ) therapy varied with clinical stability. Despite the benefit of Sacubitril / Valsartan therapy shown in the PARADIGM-HF ( ...